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Abstract 
Background. ​The Institute of Cognitive Neurology (INECO) Frontal Screening (IFS) is a brief             
neuropsychological tool recently devised for the evaluation of executive dysfunction in           
neurodegenerative conditions. ​Objective. ​In this study we present a cross-cultural validation           
of the IFS for the Portuguese population, provide normative values from a healthy sample,              
determine how age and education affect performance, and inspect its clinical utility in the              
context of Alzheimer’s disease (AD). A comparison with the Frontal Assessment Battery            
(FAB) was undertaken, and correlations with other well-established executive functions          
measures were examined. ​Methods​. The normative sample included 204 participants varying           
widely in age (20 – 85 years) and education (3 – 21 years). The clinical sample (​n = 21) was                    
compared with a sample of age- and education-matched controls (​n = 21). Healthy             
participants completed the IFS and the Mini-Mental State Examination (MMSE). In addition            
to these, the patients (and matched controls) completed the FAB and a battery of other               
executive tests. ​Results. ​IFS scores were positively affected by education and MMSE, and             
negatively affected by age. Patients underperformed controls on the IFS, and correlations            
were found with the Clock Drawing Test, Stroop test, and the Zoo Map and Rule Shift Card                 
tests of The Behavioural Assessment of the Dysexecutive Syndrome. A cut-off of 17             
optimally differentiated patients from controls. Whilst 88% of the IFS sub-tests discriminated            
patients from controls, only 67% of the FAB sub-tests did so. ​Conclusion. ​Age and education               
should be taken into account when interpreting performance on the IFS. The IFS is useful to                
detect executive dysfunction in AD, showing good discriminant and concurrent validities.  
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Introduction 
Executive functions (EF) are “supervisory” processes that coordinate cognitive,         
behavioral and emotional functions to optimize performance and pursue goals [1-6]. They            
encompass crucial abilities such as planning, working memory, cognitive flexibility, and           
inhibition [4,7,8]. Several prefrontal regions support EF, including the dorsolateral prefrontal           
and the orbitofrontal cortices, and non-frontal structures are involved as well (e.g., amygdala,             
striatum) [3,8-10]. Healthy ageing is associated with decrements in EF [11], particularly in             
planning [12,13] and inhibition [13-17]. ​EF are compromised in neurodegenerative and           
cerebrovascular disorders, such as Parkinson’s disease ​(PD) [18-20], vascular dementia (VD)           
[21,22], frontotemporal dementia (FTD) [21,23], and Alzheimer’s disease (AD) [24-28].          
Concerning AD, breakdowns in EF are noticeable in the early course of the disease, possibly               
even before standard measures of global cognitive decline can distinguish between patients            
and controls [27-29]. Balota et al. [30] found that the strongest predictor of conversion from               
healthy aging to AD was performance on a Stroop task, whereas differences in declarative              
memory were a relatively poor predictor. Consistently, Bangert and Balota [31] showed that             
decline in attentional control differentiates healthy aging from the earliest stages of AD.             
Assessing executive abilities may thus play a pivotal role for the early diagnosis of this               
disease and for the evaluation of its severity and progression [28].  
Given that comprehensive batteries of EF are time consuming and can be distressing             
for patients (e.g., Behavioral Assessment of Dysexecutive Syndrome, BADS [32];          
Neuropsychological Assessment Battery [33]), the availability of brief tools is of great clinical             
value. There are well-established tests for general cognitive screening, namely the           
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Mini-Mental State Examination (MMSE) [34] and the Montreal Cognitive Assessment [35],           
but for EF they are rare. The Frontal Assessment Battery (FAB) [36] is the most frequently                
used one [37-41]. It has very good inter-rater reliability, internal consistency, discriminant            
validity, and concurrent validity [19,36,37,41,42]. Limitations have been identified as well,           
though. Some sub-tests show poor sensitivity (e.g., prehension behavior) [19], and the battery             
as a whole fails to discriminate AD from FTD [43,44], even though specific sub-tests succeed               
in doing so (motor inhibitory control [44], mental flexibility, motor programming, and            
environmental autonomy [45]; lexical fluency [46]). It was also observed that lexical fluency,             
but not other sub-tests, is sensitive to executive dysfunction caused by cortical lesions             
restricted to the frontal cortex [47].  
Torralva, Roca, Gleichgerrcht, López, and Manes [48] designed a screening test of EF,             
the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS), aiming at providing a             
more sensitive measure of executive dysfunction in neurodegenerative conditions. It takes           
approximately 10 minutes to administer and the total score ranges between 0 and 30,              
corresponding to the sum of eight sub-tests scores. The sub-tests cover three domains             
(response inhibition and set shifting, abstraction, and working memory), and they inspect the             
following specific processes: motor programming (task: Luria’s motor series ​fist, edge, palm​),            
sensitivity to interference (conflicting instructions), inhibitory control (Go/no Go), verbal          
inhibitory control (modified Hayling test), abstraction capacity (proverb interpretation),         
working memory for digits (backward digit span), verbal working memory (months of the             
year backward), and spatial working memory (modified Corsi block tapping test; for more             
details about the sub-tests, see [48]). The tasks motor series, conflicting instructions, and             
Go/no Go were taken from the FAB, and the remaining ones were included to optimize the                
tool’s sensitivity. In the original study, the IFS showed good internal consistency, sensitivity,             
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and specificity. It discriminated healthy controls from patients with dementia, and between            
different types of dementia as well (AD and FTD). Performance on the IFS correlated with               
traditional executive measures, namely phonological fluency, Trail Making Test, and          
Wisconsin Card Sorting Test. Gleichgerrcht, Roca, Manes, and Torralva [44] observed that,            
compared to the FAB, the IFS shows stronger correlations with other executive measures and              
higher sensitivity and specificity for identifying executive dysfunction in AD and FTD. In             
another study [49], however, the (Chilean) IFS and the FAB were highly correlated (​r = .94)                
and did not differ in their ability to distinguish controls from patients with dementia of               
different etiologies. Hence, more comparisons are needed to determine whether or not the IFS              
can yield better results than the FAB. Other issues remain undetermined. First, normative             
values are currently unavailable for the IFS, and it is unknown how sociodemographic             
variables, such as age and education, affect performance. Neuropsychological tests can be            
influenced by these variables [19,37,50-53], and it is important that they are considered when              
interpreting whether a score reflects impairment or not. Second, the IFS is available in              
English, Spanish [48] and Chilean [49], but adaptations for other cultural backgrounds are             
lacking. These will be critical before it can be widely used, as previously observed for other                
screening tools [19,54]. Third, preliminary evidence indicates that the IFS is sensitive to             
executive dysfunction in AD [44,48], but a follow-up of these findings would be enlightening.              
A comparison of AD patients and controls across each of the sub-tests has not been               
conducted, and a cut-off has not been generated. Moreover, the available evidence does not              
explore the possible role of depression symptoms, and the comparison between controls and             
AD patients by Torralva et al. [48] is limited by the fact that the two groups were not                  
age-matched.  
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The goals of the present study were to adapt the IFS for the Portuguese population, to                
collect normative data from a cognitively healthy sample, to examine the impact of             
sociodemographic variables on performance, and to investigate its clinical utility in AD            
(discriminant validity). We hypothesized that performance would be positively influenced by           
education and negatively influenced by age, and impaired in AD as compared to healthy              
controls. We also compared the IFS and the FAB regarding sensitivity and specificity. To              
investigate concurrent validity, we analyzed correlations with well-established and ecological          
measures of EF, namely the Stroop test [55], Clock Drawing Test [56], and the Zoo Map Test                 
and Rule Shift Card of the BADS [32].  
 
Materials and Methods 
Participants  
A total of 204 participants were included in the normative study (143 female), varying              
widely in age and education (see Table 1). Age ranged between 20 and 85 years (​M = ​44.98;                  
SD ​= 21.23), and education ranged between 3 and 21 years (​M = ​10.52; ​SD = ​4.82). All                  
participants were European Portuguese native speakers, living in rural, suburban, and urban            
regions of Portugal, mainly northern. To ensure that they were cognitively healthy,            
participants were interviewed by a psychologist and were included only if they were             
autonomous in daily living activities, and had no history of alcoholism/substance abuse, brain             
injury, neurological/psychiatric conditions, or other conditions which may impact on          
cognition. Normal performance on the MMSE [34,57] was required (the Portuguese cut-offs            
were used: 22, 24 and 27 for 0-2, 3-6 and > 12 years of education, respectively [52]). Eleven                  
of the initial 215 participants who volunteered to take part were excluded. The final sample               
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scored high on the MMSE (​M = 29.15; ​SD = 1.19; range for participants aged 20 – 44 years =                    
27 – 30, 45 – 64 years = 24 – 30, > 65 years = 25 – 30).  
The AD sample consisted of 21 patients (14 female) recruited through the Centro             
Hospitalar de Entre o Douro e Vouga, Portugal. The diagnosis of “Probable AD dementia              
with evidence of the AD pathophysiological process” was confirmed by experienced           
neurologists based on the criteria of the Institute of ​Neurological and Communicative            
Disorders and Stroke and Alzheimer's Disease and Related Disorders Association          
(NINCDS-ADRDA [58]). All patients underwent detailed neurological, neuropsychological        
and structural neuroimaging (magnetic resonance imaging or computerized axial tomography)          
examinations. In two cases, the disease was further characterized with a cerebrospinal fluid             
analysis (amyloid-beta protein deposition and both total tau and phosphorylated tau).           
According to the Global Deterioration Scale [59] (Portuguese version [60]), all patients had             
early dementia (stage 4), showing clear-cut deficits on clinical interview and difficulties            
dealing with challenging tasks/situations, but being still able to live with no or minimal              
assistance. At the moment of testing, 12 patients were medicated with AD/memory-related            
medication (donezepil, n = 4; memantine, n = 3; rivastigmine, n = 2; Ginkgo Biloba, n = 2;                  
vinpocetina, n = 1), 8 were taking antidepressants and benzodiazepines, and 1 was taking              
neuroleptics. No comorbid conditions were identified, apart from mild heart disease in 2             
patients (patients with conditions such as stroke, traumatic brain injury, alcoholism and            
substance abuse, infections or major psychiatric disorders were not included). The patients            
performed 23.33 on the MMSE (​SD = ​3.84; range = 14 – 30; for similar scores on patients                  
with AD, see [44,45,46]). Mean age for the AD sample was 74.57 years (​SD = ​4; range = 65 –                    
85) and mean education was 3.67 years (​SD = ​0.48; range = 3 – 6). This education level is                   
lower than the one observed in several studies [31,44,47,61-63], but it is representative of the               
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majority of Portuguese elderly population. According to Censos 2011 [64], the majority of             
people over 65 years in Portugal completed only what is currently known as 1​st ​Cycle of Basic                 
Education, which corresponds to 4 years (67.27%, 62.65%, and 56.80% of the people aged              
65-69 years, 70-74 years, and 75-79 years, respectively). Depression symptoms were           
controlled for using the Geriatric Depression Scale [65] (Portuguese version [66]). As            
indicated in Table 3, the patients’ average score on this scale was 9.9 (scores ≥ 11 are                 
suggestive of depression [65,66]). Patients who scored above the cut-off on this scale were              
not excluded (​n = 10) on the basis of evidence that depression symptoms are highly prevalent                
in early AD [67,68,69] and that common neuropathological mechanisms may underlie the two             
conditions [70,71]. This study was approved by the ethics committee of Centro Hospitalar de              
Entre o Douro e Vouga, and performed in accordance with the 1964 Declaration of Helsinki               
and its later amendments. Informed consent was obtained from all participants. 
 
 Table 1 here  
 
Materials  
Participants were tested in a single session conducted by a psychologist experienced in             
neuropsychological assessment. Healthy participants underwent a clinical interview to collect          
sociodemographic and clinical information, including current health status and medical          
history, after which they completed the MMSE and the IFS, recently translated and adapted              
for the Portuguese population by our group. The IFS was first translated into Portuguese from               
the original Spanish and English versions [48] by two independent researchers; both            
researchers were Portuguese native speakers, and they were proficient in English and fluent in              
reading Spanish. These translations were compared and the inconsistencies solved. A           
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preliminary version was discussed regarding content validity with several experts in           
neuropsychological assessment. To make the IFS appropriate for the Portuguese          
linguistic/cultural context, the Proverbs sub-test was adapted to include only items frequently            
used in Portugal: “Cão que ladra não morde” (“Dog that barks does not bite”, same as in the                  
original Spanish version); “Mais vale um pássaro na mão do que dois a voar” (“A bird in the                  
hand is worth two in the bush”, same as in the original English version); and “Mais vale                 
prevenir do que remediar” (“Better safe than sorry”, new item). After reaching consistency for              
all verbal instructions and performing pilot administrations, the final version was produced.            
The Portuguese-IFS is freely available from the authors upon request.  
Concerning AD patients, a comprehensive neuropsychological assessment was        
conducted. In addition to the MMSE and the IFS, they completed the Global Deterioration              
Scale and the Geriatric Depression Scale, as mentioned above. Furthermore, they completed            
classical measures of EF, namely the FAB [36] ​(Portuguese version [19]) and the Stroop test               
[55], as well the Clock Drawing Test [56]. They also completed two tests of the BADS [32], a                  
battery designed to assess EF in a more complex and ecological way: the Zoo Map Test,                
which assesses the ability to formulate and implement a plan, and the Rule Shift Card, which                
assesses perseverative tendencies and mental flexibility.  
To analyze the clinical utility of the IFS in AD, the patients were compared with a                
sample of 21 controls, who were selected from the healthy normative sample. To guarantee              
comparability, care was taken to match patients and control regarding age, education, and             
magnitude of depression symptoms (for details about the background and neuropsychological           
characteristics of patients and controls, see Table 3). The two groups underwent the same              
neuropsychological assessment battery.  
Statistical analysis 
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To examine the influence of sociodemographic variables (age, education and gender)           
and global cognitive functioning (MMSE) on the IFS scores, a stepwise multiple linear             
regression analysis was conducted on the normative sample (healthy participants, ​N = ​204).             
Internal consistency was investigated with Cronbach’s alpha coefficient. Differences between          
AD patients and matched controls regarding performance on the IFS and FAB (total scores              
and subscores) and on the other executive tests were explored with independent samples             
Student’s t-tests. An analysis of covariance (ANCOVA) was conducted, including education           
and MMSE scores as covariates, to determine whether group differences in the IFS remain              
significant after partialling out variability in these confounds. A receiver operating           
characteristic (ROC) curve analysis was carried out to examine the IFS           
diagnostic/discriminatory accuracy, and to determine the optimal cut-off to differentiate          
patients from controls. The same analysis was computed on the FAB scores and results were               
compared. To investigate concurrent validity with other executive tests, Pearson correlations           
were computed. Partial correlations controlling for age, education and MMSE were also            
computed to ensure that the identified associations between executive tests are not artifacts of              
variability in these confounds. All effects were considered significant at ​p ​< .05 (uncorrected);              
we report exact ​p values (unless they are < .001) and effect sizes in the text. Significant                 
differences at a more stringent level of ​p​ < .001 are signaled in the tables . 1
1 Bonferroni adjustments were not used as that they may be very conservative, particularly 
when the number of comparisons is large and when the tests are not independente [72,73].  
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Results 
Normative values and the role of sociodemographic variables  
Table 2 depicts the mean values and standard deviations for the total IFS scores as a                
function of age and education. The mean IFS score observed across the entire sample was               
23.49 (​SD = 4.13). Age, gender, number of years of education, and MMSE score entered the                
multiple linear regression model as predictors, and the total IFS score as dependent variable.              
The resulting model excluded gender, and it included age, education and MMSE as significant              
predictors, which were able to explain, altogether, 52,7% of the total variance [adjusted ​R​2 =               
.53, ​F​(3,203) = 74.42, ​p < .001]. Education was the strongest predictor, with longer education               
predicting higher IFS scores [β = .432, ​t = 6.76, ​p < .001], and it was followed by age and                    
MMSE. Advancing age predicted lower IFS scores [β = - .232, ​t = -3.90, ​p < .001], and better                   
performance on the MMSE predicted higher IFS scores [β = .201, ​t ​= 3.41, ​p = .001]. To                  
summarize, the IFS total score was higher in younger and more educated individuals with              
higher performance on the MMSE.  
The Portuguese-IFS showed acceptable internal consistency, as indicated by a          
Cronbach’s alpha coefficient between subscores of .69.  
 
Table 2 here  
 
The utility of the IFS in Alzheimer’s disease 
The performance of AD patients and matched healthy controls on EF tests is described              
in Table 3. Independent samples t-tests revealed that the patients underperformed controls on             
the traditional standardized measures of EF, namely the Stroop test and the Clock Drawing              
Test, as well as on the more ecological tests taken from the BADS, the Zoo Map Test (raw                  
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score and execution time of Condition 2) and the Rule Shift Card (errors in Condition 2). The                 
patients also had difficulties on the FAB, the most frequently used screening tool of EF. Thus,                
the patients sampled here had significant executive impairments, a result consistent with            
previous literature on AD [15-17,24,25,27,29]. 
Discriminant validity. ​To examine whether the IFS is sensitive to executive           
dysfunction in AD, we first compared the total scores across groups. As can be seen in Table                 
3, the patients’ scores were significantly worse (11.38) than controls’ (20.1), with the patients              
scoring 8.72 points lower than controls, ​F​(1,41) = 30.22, ​p < .001, η​p​2 ​= .43 (this difference                 
was numerically similar to the one reported by Torralva et al. [48], 7.3 points). This effect                
was further confirmed by an ANCOVA with education and MMSE as covariates, ​F​(1,38) =              
4.91, ​p = .03; η​p​2 = .11 (education and MMSE were included as covariates because these                 
variables correlate with the IFS total score, ​r = .33, ​p = .04 and ​r = .73, ​p < .001,                    
respectively). These results indicate that the IFS presents good discriminant validity in AD.             
The fact that the differences between groups were not reducible to differences in the MMSE               
suggests that the IFS is selectively tapping on the patients’ executive difficulties, and not only               
on their general cognitive impairment.  
To examine possible differences in performance across sub-tests, we compared the           
two groups on their scores for each individual task. These results are presented in Figure 1,                
which for comparison purposes also presents scores for the FAB sub-tests. Independent            
samples t-tests showed that AD patients performed significantly worse than controls on the             
three sub-tests which are common to the IFS and the FAB, as well as on four out of the five                    
sub-tests which are specific to the IFS: motor series [​t​(40) = -4.005, ​p < .001], conflicting                
instructions [​t ​(40) = -3.55, ​p = .001], Go/no go [​t​(40) = -3.38, ​p = .002], verbal working                 
memory [​t​(40) = -2.96, ​p = .006], spatial working memory [​t​(40) = 2.40, ​p = .001], proverbs                 
12 
 
[​t​(40) = -2.71, ​p = .01], and Hayling test [​t​(40) = -4.67, ​p = .02]. Thus, only one sub-test of                    
the IFS was insensitive to group differences, the backward digit span (​p =. 29). Concerning               
the sub-tests specific to the FAB, only similarities discriminated AD patients from controls             
[​t​(40) = -5.43, ​p < .001]. Differences were non-significant for lexical fluency and prehension              
behaviour (​p​s = .12 and .32, respectively).  
 
Table 3 here 
 
Figure 1 here  
 
Diagnostic accuracy. ​To further investigate how the IFS discriminated AD patients           
from controls, a ROC curve analysis was carried out on the IFS total score between the two                 
groups. This analysis generated an optimal cut-off score of 17 points, with sensitivity of              
76.2% and specificity of 81%. The area under the curve (AuC) was .88, CI = [.78, .90], ​SE =                   
.052. This level of specificity satisfies The Ronald and Nancy Reagan Research Institute of              
the Alzheimer’s Association’s [74] recommendations for ideal biomarkers of AD (no less            
than 80%), and the obtained level of sensitivity approaches the recommendations as well (also              
80%). It is noteworthy that these results were attained with a purely behavioral, simple, quick               
and inexpensive tool as the IFS.  
There were no noticeable differences between the IFS and the FAB regarding            
diagnostic accuracy, as indicated by a ROC curve analyses on the FAB total score. The area                
under the curve was highly similar to the one found for the IFS, .87, CI = [.76, .98], ​SE =                    
.057. A cut-off of 13 was generated, with sensitivity of 81% and specificity of 71%. The fact                 
that the IFS and the FAB sub-tests partially overlap may contribute to explain this null result,                
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but note also that the original hypothesis of the authors was that by introducing new sub-tests                
in the IFS (and not including some of the FAB ones) there would be gains in terms of                  
sensitivity and specificity [48].  
 
Figure 2 here  
 
Concurrent validity. ​Table 4 presents the correlation coefficients, as well as partial            
coefficients, which were calculated taking into account sociodemographic variables,         
specifically age and education (and performance on the MMSE, in the case of correlations              
with other measures of EF). As can be seen, significant correlations were found between the               
IFS and other measures of EF, namely Clock Drawing Test, Zoo Map Test (raw score and                
execution time in condition 2), and Rule Shift Card (errors in conditions 1 and 2). These were                 
lower when possible confounds were partialled out, but they were still significant (except for              
execution time in condition 2 of Zoo Map Test, and for errors in condition 1 of Rule Shift                  
Card). These results indicate that the IFS has good concurrent validity. Replicating previous             
findings, the IFS also correlated with performance on the MMSE [48,49]. Importantly, no             
associations were found with the magnitude of the depression symptoms. For comparison            
purposes, the same analyses were computed for the FAB scores: it also correlated with other               
measures of EF (Clock Drawing Test, raw score and execution time in condition 2 of Zoo                
Map Test, and errors in condition 1 and 2 of Rule Shift Card) and MMSE, but not with                  
depression.  
 
Table 4 here  
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Comparing the IFS and the FAB. ​As mentioned above, AD patients scored lower than              
controls in both the IFS and the FAB, and the diagnostic accuracy of the two tests was similar,                  
as indicated by similar areas under the curve in the ROC curve analyses. With respect to                
concurrent validity, both tests correlated with a number of other EF measures, and they also               
correlated strongly with each other, ​r = .83 (for a high correlation between the IFS and the                 
FAB, ​r = .94, see also Ihnen et al. [49]). Thus, for the participants sampled here, both the IFS                   
and the FAB showed evidence of good validity and diagnostic accuracy. Concerning            
sub-tests, though, while 88% of the IFS tasks discriminated patients from controls (7 out of               
8), only 67% of the FAB tasks did so (4 out of 6). Thus, the IFS includes a higher proportion                    
of sensitive sub-tests than the FAB.  
 
Discussion 
To provide a brief and simple tool for evaluating executive dysfunction in            
neurodegenerative conditions, Torralva et al. [48] recently designed the IFS. The present            
study revealed four main findings. First, after translating and adapting the IFS for the              
Portuguese population, we collected normative values from healthy individuals and observed           
that performance is influenced by age and education. Second, appropriate internal consistency            
was obtained, as measured by Cronbach’s alpha in healthy participants. Third, we showed that              
the IFS is useful to inspect executive dysfunction in AD: patients’ total scores were lower               
than controls’ (discriminant validity); a cut-off of 17 produced a good AuC and an optimal               
balance between sensitivity and specificity (diagnostic accuracy); the patients presented          
impaired performance for all IFS sub-tests, except for backward digit span; and the IFS              
correlated with other well-established measures of EF (concurrent validity). Fourth, in           
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comparison with the FAB, more sub-tests of the IFS were sensitive to executive dysfunction              
in AD. These findings are discussed next.  
As expected, performance on the IFS decreased as a function of age and increased as a                
function of education. The influence of age and education on performance on            
neuropsychological tests, namely on screening tools, has been consistently reported in the            
literature [8,56,75,76]. For instance, similar findings were previously observed for the FAB            
[19,37,38] and for the two most frequently used screening tools of general cognition, the              
MMSE [18,52,76,77] and the Montreal Cognitive Assessment [51,53,78-80]. To our          
knowledge, our study is the first one looking at the role of these sociodemographic variables               
in the context of the IFS. These results highlight that, when using the IFS in research and                 
clinical contexts, it is crucial to interpret individual or group scores taking into account age               
and education level. In fact, this is a well-established practice in cognitive and             
neuropsychological testing, particularly in what respects to age [51,52,81]. Concerning the           
possible mechanisms underlying these effects, it is known that advancing age is associated             
with decline in EF [12,81,82], and this may explain why older participants scored lower than               
younger ones on the IFS. That lower education may be associated with worse scores in               
executive performance is consistent with previous evidence: Pavão Martins et al. [83], for             
instance, found that older adults with lower education score lower than those with higher              
education in several EF tasks (Trail Making Test, Symbol Search, Matrix reasoning, Semantic             
and phonemic verbal fluencies, Stroop test; digit span); note that possible confounds were             
excluded, such as lack of health care or extreme poverty, suggesting that the effect of               
education is a direct one. Having access to education may increase familiarity with evaluation              
contexts, as well as increase practice on tasks similar to the ones included in              
neuropsychological tests, which may explain the positive effects we uncovered. We have also             
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found that the MMSE scores predict performance on the IFS. This is in line with previous                
research on the relationship between general cognitive functioning and performance on EF            
measures [19,44,48,49,84]. It may partly reflect the fact that the MMSE taps on executive              
processes to a significant extent (e.g., sub-tests attention and calculation, language, and            
3-stage command).  
That the IFS presented evidence of acceptable internal consistency lends credence to            
earlier studies with other versions of this tool, namely English, Spanish and Chilean [44,              
48,49], and extends their findings to the Portuguese version. This suggests that the             
psychometric properties of the IFS are robust across languages and cultural settings. Thus, we              
consider that it can be used with confidence in the Portuguese population.  
Regarding the utility of the IFS to evaluate executive dysfunction in AD, both the total               
score and all subscores individually (except for backward digit span) were effective at             
discriminating patients from healthy controls. These results further confirm the findings by            
Torralva et al. [48]. They also add to the findings by Gleichgerrcht et al. [44]: as in the present                   
study, they observed that AD patients perform worse than age- and education-matched            
controls on the IFS, but possible differences in sensitivity across sub-tests were not             
considered. Therefore, our findings contribute to establish the clinical value of the IFS in AD               
by showing a reduction in total scores in a new sample of patients, and by showing for the                  
first time that most IFS sub-tests are sensitive to EF difficulties in this disease. Furthermore,               
in previous studies depression symptoms were not evaluated [48], or they were higher in the               
clinical sample than in controls [44], making it difficult to discern whether patients’             
reductions relative to controls are a specific effect of the disease or an effect of depression                
symptoms. This issue is clarified here: patients and controls were matched for the magnitude              
of depression symptoms and, crucially, we observed that performance on the IFS and             
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depression symptoms are not correlated. In terms of diagnostic accuracy, the optimal cut-off             
revealed by our ROC curve analysis was 17, which is similar to the one found recently by                 
Ihnen et al. [49] for the Chilean version of the IFS (18 points), in a study including health                  
controls and patients with several types of dementia. This cut-off is lower than the one               
reported in the original study (25 points), though [48]. This discrepancy is probably related to               
differences in education levels between samples. While participants in Torralva et al.’s study             
attended school for around 15 years, in our sample they attended school for 4 years only. This                 
explanation is in line with the positive association we found between education and             
performance on the IFS. These differences are further evidence that accuracy in the             
interpretation of scores on this battery depends on considering the moderating role of             
sociodemographic factors.  
One of the goals of the present study was to investigate the concurrent validity of the                
IFS. Significant correlations were uncovered between scores on this battery and scores on             
several other measures of EF, specifically Clock Drawing Test, Zoo Map Test (Condition 2)              
and Rule Shift Card. These results attest the concurrent validity of the IFS, and they extend                
the findings of the original study [48], in which correlations were found with different EF               
measures, phonological fluency, Trail Making Test, and Wisconsin Card Sorting Test (see            
also [44]). Regarding the Clock Drawing test, however, note that impairments in AD reflect              
executive dysfunction, but they may also reflect visuospatial and constructional problems to            
some extent [85]. It is noteworthy that two of the tests of EF we used, the Zoo Map Test and                    
the Rule Shift Card, were taken from the BADS, a battery designed to include ecologically               
valid tasks which can predict daily life difficulties more effectively than           
standardized/conventional measures [17,86]. Finding that a standardized screening tool like          
the IFS correlates with ecological measures of EF is highly relevant in terms of its clinical                
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value – it suggests that this simple tool may provide information which is predictive of daily                
life functioning, even though it is brief and easy to administer. In the future it will be                 
important to determine whether the IFS is also predictive of behavioral and emotional             
symptoms, as assessed using tools such as the Frontal Behavioral Inventory [87].  
The IFS was developed in an attempt to provide a more sensitive index of executive               
dysfunction than the FAB, which has become the most extensively used screening tool of EF               
in the last years. We observed that they both have good discriminant validity, diagnostic              
accuracy, and concurrent validity. Our results confirm previous research showing that the            
FAB is sensitive to executive dysfunction in AD [88,89] and correlates with other measures of               
EF [19,38,39,41]. Nevertheless, the fact more sub-tests of the IFS (7 out of 8, 88%) than of                 
the FAB (4 out of 6, 67%) discriminated AD patients from controls suggests that the IFS may                 
provide more fine-grained information about the patients’ difficulties. Additionally, in          
comparison with the FAB, the IFS may be especially useful when testing younger and more               
educated individuals because it is less prone to ceiling effects. While highly educated younger              
participants were shown to perform at maximum levels in the FAB [19,37], the same was not                
found here for the IFS (see results; an inspection of Table 2 suggests that floor effects are also                  
unlikely, even for older and lower educated individuals). In contrast to Gleichgerrcht et al.              
[44], though, we did not find advantages of the IFS over the FAB in terms of diagnostic                 
accuracy and strength of the correlations with other EF measures. Additionally, in line with              
Ihnen et al. [49], we found a very high correlation between the IFS and FAB, ​r > ​.8,                  
suggesting that they cover the same underlying processes to a large extent. Hence, the issue of                
the relative clinical usefulness of the two tests calls for more detailed exploration in the               
future. The same holds true regarding whether they are sensitive to executive dysfunction at              
very early pathological stages, such as in mild cognitive impairment. Preliminary evidence            
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indicates that the FAB may be able to differentiate amnestic mild cognitive impairment and              
early stage AD [90], but evidence for this on the IFS is lacking, as are comparisons between                 
the two tools and with healthy controls. Another relevant question will be to determine              
whether performance in brief tools like these can distinguish a frontal variant of AD from               
typical AD, which may involve distinct clinical and pathological features [91].  
In conclusion, the results of the present study establish that (a) performance on the IFS               
is influenced by sociodemographic variables, notably age and education, and that (b) this             
screening tool is effective at detecting executive dysfunction in AD. They suggest that the IFS               
can provide valuable information for the diagnosis of this disease, and set the stage for future                
studies to determine whether it is also suitable to monitor its progression over time. The               
clinical value of this tool was further confirmed by correlations with other measures of              
executive functioning, namely with measures related to real life situations. In addition, the             
validated Portuguese version of the IFS, which we make available here, and the normative              
data from a healthy sample, will contribute greatly to improve the confidence and accuracy in               
the utilization of this tool with Portuguese speaking patients in research and clinical contexts.  
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Table 1. ​Demographic distribution of the healthy sample as a function of education and age               
(​N ​= 204)  
 
 
Education (years) 
Age (years) 
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20-44 45-64 > 65 Total 
1-4 1 (M1/F0) 16 (M3/F13) 30 (M11/F19) 47 (M15/F32) 
5-12 36 (M18/F18) 28 (M8/F20) 10 (M4/F6) 74 (M30/ F44) 
>12 61 (M11/F50) 13 (M2/F11) 9 (M3/F6) 83 (M16/F67) 
Total 98 (M30/F68) 57 (M13/F44) 49 (M18/F31) 204 (M61/F143) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Mean total IFS scores for the healthy sample (​N = 204) as a function of education                  
and age. Standard deviations are given in parentheses.  
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 Education (years) 
Age (years) 
20-44 45-64 > 65 Total (all age levels) 
1-4 (Primary) 16.5 20.8 (2.9) 18.9 (4.2) 19.5 (3.9) 
SD​a - 18, 16, 15 15, 13, 11 16, 14, 12 
     
5-12 (Middle and High) 24.6 (2.8) 22.0 (3.8) 20.8 (2.6) 23.10 (3.5) 
SD 22, 20, 19 18, 16, 14 18, 17, 16 20, 18, 16 
     
>12 (University) 26.3 (2.6) 25.6 (3.0) 25.2 (2.9) 26.08 (2.7) 
SD 24, 22, 21 23, 21, 20 22, 21, 19 23, 22, 21 
     
Total (all education levels) 25.6 (2.9) 22.5 (3.8) 20.4 (4.4) 23.5 (4.1) 
SD 23, 21, 20 19, 17, 15 16, 14, 12 19, 17, 15 
a ​IFS values below 1 SD, 1.5 SDs, and 2 SDs, respectively 
 
 
 
 
 
 
 
 
 
Table 3. Background and neuropsychological characteristics of patients with Alzheimer’s          
disease (AD) and healthy controls  
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 AD Patients (​n​ = 21) Healthy Controls (​n​ = 21)  
Measures M (SD) Range M (SD) Range p 
Age (years) 74.57 (4) 65-85 75.43 (5.16) 65-85 .55 
Education (years) 3.67 (0.48) 3-6 4.48 (3.18) 2-15 .25 
Gender (M:F) 14:7 - 15:6 -  
MMSE (/30; cut-off 24) 23.33 (3.84) 14-30 28.24 (1.3) 26-30  < .001 
GDS (/30) 9.90 (4.69) 3-19 8.62 (5.2) 3-18 .41 
Clock Drawing Test (/5) 2.33 (1.32) 0-5 4.10 (1.14) 2-5 < .001 
Stroop Test (interference index) 4.67 (9.9) -13-36 10.29 (6.46) 1-23 .03 
Zoo Map Test      
 Condition1      
 Raw score (/8) 2.86 (2.87) 0-8 4.19 (3.04) 0-8 .​15 
 Planning time (s) 29.05 (58.24) 0-255 36.83 (38.06) 1-147 .​97 
 Execution time (s) 158.81 (70.26) 53-311 161.10 (60.63) 75-270 .91 
Condition 2      
 Raw score (/8) 5.67 (2.46) 0-8 7.19 (1.12) 4-8 .01 
 Planning time (s) 4.48 (5.86) 0-19 5.67 (9.31) 0-42 .62 
 Execution time (s) 123.76 (57.1) 48-232 79.62 (25.19) 44-150 .002 
Rule Shift Card      
 Errors Condition 1 (/20) 0.67 (1.24) 0-4 .10 (.3) 0-1 .​05 
 Errors Condition 2 (/20) 7.00 (2.86) 1-10 2.52 (2.58) 0-10 < .001 
IFS (/30) 11.38 (5.47) 4.5-23 20.10 (4.78) 11.5-26 < .001 
FAB (/18) 9.95 (3.11) 5-17 15.0 (3.03) 8-18 < .001 
Note:​ ​M = male. F = female. MMSE = Mini-Mental State Examination. GDS = Geriatric Depression Scale. IFS = Institute 
of Cognitive Neurology Frontal Screening. FAB = Frontal Assessment Battery. Values in bold correspond to significant 
differences between AD patients and controls.  
 
 
Table 4. Correlations between the IFS and FAB total scores, other measures of executive              
functioning, MMSE, and magnitude of depression symptoms  
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  IFS total score  FAB total score 
Measures r Partial r​a  r Partial r​a 
IFS total score -  -  .92** .83** 
FAB total score .92** .83**  - - 
Clock Drawing Test  .75** .51*  .80** .62** 
Stroop Test (interference index) .16 -.14  .09 -.21 
Zoo Map Test      
    Condition 1      
  Raw score  .19 .28  .23 .31* 
  Planning time  .25 .03  .19 .06 
  Execution time  .06 -.04  -.025 -.16 
    Condition 2      
  Raw score .43** .31*  .39* .26 
  Planning time  .05 -.06  .05 -.05 
  Execution time  -.57** -.30  -.64** -.44* 
Rule Shift Card      
    Errors Condition 1  -.39* -.21  -.35* -.18 
    Errors Condition 2  -.63** -.35*  -.65** -.43* 
MMSE .73** .72**  .69** .67* 
Geriatric Depression Scale -.17 -.02  -.16 -.05 
 
Note: ** ​p​ < .001; *​ p​ < .05. ​a ​Controlled for sociodemographic variables (age and education) and MMSE, in the case of 
correlations with other measures of EF.  
 
 
 
 
 
Figure Captions  
36 
 
 Figure 1. Scores of patients with Alzheimer’s disease (AD) and matched healthy controls on              
each of the IFS and FAB sub-tests  
 
Figure 2. Receiver Operating Characteristic (ROC) curves of the IFS and the FAB in              
comparing Alzheimer’s disease patients versus healthy controls  
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Figure 1. 
 
 
 
Note: * ​p ​ < .05. MS = motor series. CI = conflicting instructions. GNG = Go/no go. BDS = backward digit span. VWM = 
verbal working memory. SWM = spatial working memory. PRO = proverbs. HT = Hayling test. SIM = similarities. LF = 
lexical fluency. PB = prehension behavior 
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Figure 2.  
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